Discover our extensive collection of research-grade antibodies,
rigorously validated for in vivo applications.
Precisely identify antibody-specific signals using matched isotype controls optimised for in vivo experimentation.
BiosimilarsInvestigate biological therapeutic mechanisms with cost-effective, research-grade biosimilar antibodies.
This biosimilar antibody has the same variable regions as therapeutic Panitumumab, ideal for research. Panitumumab, a fully humanized IgG2κ mAb, binds wild-type human EGFR and its mutant EGFRvIII. EGFR mediates cell signaling; Panitumumab blocks its activation, inhibiting cell growth, inducing apoptosis. In vitro/in vivo studies show it arrests cell cycle and suppresses tumor growth.
| Product Name | BioSIM anti-Human EGFR Antibody (Panitumumab Biosimilar), Research Grade |
| Size | 1mg/5mg |
| Isotype | IgG2-kappa |
| Target | EGFR |
| Other Names | ABX-EGF, E7.6.3, CAS: 339177-26-3 |
| CAS | 339177-26-3 |
| Reactivity | Human |
| Host Species | Human |
| Background | This biosimilar antibody has the same variable regions as therapeutic Panitumumab, ideal for research. Panitumumab, a fully humanized IgG2κ mAb, binds wild-type human EGFR and its mutant EGFRvIII. EGFR mediates cell signaling; Panitumumab blocks its activation, inhibiting cell growth, inducing apoptosis. In vitro/in vivo studies show it arrests cell cycle and suppresses tumor growth. |
| Applications | ELISA, FACS, Functional assay, Research in vivo |
| Purification | Protein A/G |
| Storage | To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Shipping | 2-8°C with blue ice |
| Concentration | Lot specific, generally ≥ 5.0 mg/ml |
| Shelf Life | 12 months from the date of receipt if stored as recommended |
| Formulation | PBS, pH 7.4, contains no stabilizers or preservatives |
| Sterility | 0.2 μM filtered |
| Endotoxin | ≤ 1.0 EU/mg |
| Purity | 99% |







